Sodium-Glucose Cotransporter-2 Inhibitors and Risk of Retinal Vein Occlusion among Patients with Type 2 Diabetes: A Propensity Score-Matched Cohort Study

被引:0
|
作者
Lee, Min-Kyung
Han, Kyungdo
Kwon, Hyuk-Sang
Roh, Young-Jung
机构
关键词
D O I
10.2337/db21-128-LB
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
128-LB
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinal Vein Occlusion Among Patients With Type 2 Diabetes: A Propensity Score-Matched Cohort Study
    Lee, Min-Kyung
    Kim, Bongsung
    Han, Kyungdo
    Lee, Jae-Hyuk
    Kim, Minhee
    Kim, Mee Kyoung
    Baek, Ki-Hyun
    Song, Ki-Ho
    Kwon, Hyuk-Sang
    Roh, Young-Jung
    DIABETES CARE, 2021, 44 (10) : 2419 - 2426
  • [2] Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinal Vein Occlusion Among Patients With Type 2 Diabetes: A Propensity Score-Matched Cohort Study. Diabetes Care 2021; 44:2419-2426
    Lee, Min-Kyung
    Han, Kyungdo
    Kwon, Hyuk-Sang
    DIABETES CARE, 2022, 45 (02) : E38 - E38
  • [3] Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score-matched Population-based Cohort Study
    Alkabbani, Wajd
    Zongo, Arsene
    Minhas-Sandhu, Jasjeet K.
    Eurich, Dean T.
    Shah, Baiju R.
    Alsabbagh, Mhd Wasem
    Gamble, John-Michael
    CANADIAN JOURNAL OF DIABETES, 2022, 46 (04) : 392 - +
  • [4] Association between Sodium-Glucose Cotransporter-2 inhibitors and depression in chronic heart failure: A Tunisian propensity score-matched cohort study
    Noamen, A.
    Ben Amara, A.
    Ben Ayed, H.
    Ben Youssef, Y.
    Hajlaoui, N.
    Fehri, W.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 309 - 310
  • [5] Sodium-glucose cotransporter-2 inhibitors and the risk of lung cancer among patients with type 2 diabetes
    Shapiro, Samantha B.
    Yin, Hui
    Yu, Oriana H. Y.
    Azoulay, Laurent
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (05) : 1365 - 1370
  • [6] Sodium-glucose Cotransporter-2 Inhibitors and Risk of Hepatocellular Carcinoma Among Patients With Type 2 Diabetes
    Bea, Sungho
    Jeong, Han Eol
    Kim, Jae Hyeon
    Yu, Oriana Hy
    Azoulay, Laurent
    Shin, Ju-Young
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (13) : 3451 - +
  • [7] Sodium-glucose cotransporter-2 inhibitors and the risk of lung cancer among patients with type 2 diabetes
    Shapiro, Samantha B.
    Yin, Hui
    Yu, Oriana Hoi Yun
    Azoulay, Laurent
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 349 - 349
  • [8] Type Disparity in Sodium-Glucose Cotransporter-2 Inhibitors in Incidences of Renal Cell Carcinoma: A Propensity-Score-Matched Cohort Study
    Lin, Tsung-Kun
    Wang, Wei-Yao
    Yang, Tsung-Yuan
    Jong, Gwo-Ping
    CANCERS, 2024, 16 (11)
  • [9] Sodium-glucose cotransporter-2 inhibitors and risk of hepatocellular carcinoma among patients with type 2 diabetes: A population-based cohort study
    Bea, Sungho
    Jeong, Han Eol
    Noh, Yunha
    Park, Sohee
    Sinn, Dong Hyun
    Kim, Jae Hyeon
    Yu, Oriana H. Y.
    Azoulay, Laurent
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 57 - 58
  • [10] Risk of hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: A nationwide cohort study
    Bea, Sungho
    Jeong, Han Eol
    Park, Sohee
    Chang, Yoosoo
    Sinn, Dong Hyun
    Yu, Oriana Hoi Yun
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 7 - 8